SCHEMBL4165013

SCHEMBL4165013

CN(C)c1ccc(C=C2c3ccccc3CCc3ccccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.56
MAOA P21397 2/20 0.56
MAPT P10636 6/20 0.52
ALDH1A1 P00352 6/20 0.52
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
APP P05067 4/20 0.52
SNCA P37840 4/20 0.52
LMNA P02545 3/20 0.52
CYP1A2 P05177 3/20 0.52
PDGFRB P09619 2/20 0.52
MAPK1 P28482 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
MTOR P42345 2/20 0.52
CYP2D6 P10635 2/20 0.52
PKM P14618 2/20 0.52
PMP22 Q01453 2/20 0.52
TP53 P04637 2/20 0.52
CYP3A4 P08684 2/20 0.52
NPC1 O15118 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508434 0.86 CYP19A1 (0.44) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL136295 0.84 MAPT (0.59) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL12998636 0.83 MIF (0.55) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL4160758 0.83 AR (0.54) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL14589690 0.81 MAOB (0.66) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL8547082 0.80 MAOB (0.77) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL29013399 0.80 MAOB (0.77) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL8547081 0.80 MAOB (0.77) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL29546505 0.80 MAOB (0.77) MAOBMAOAMAPTALDH1A1MEN1
SCHEMBL9803755 0.78 MAPT (0.54) MAOBMAOAMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS COGHLAN MICHAEL JOSEPH 2009-06-11 US disclosed
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS COGHLAN MICHAEL JOSEPH 2009-06-11 US disclosed
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS COGHLAN MICHAEL JOSEPH 2009-06-11 US disclosed
US-7411072-B2 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2008-08-12 US disclosed
US-7411072-B2 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2008-08-12 US disclosed
US-7411072-B2 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2008-08-12 US disclosed
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2006-03-23 US disclosed
WO-2004052847-A2 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS NR5A1, NR3C2, NR3C1 MAOB 2154/4885MAOA 2086/4885MAPT 3591/4885
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators NR5A1, NR3C2, NR3C1 MAOB 2012/4885MAOA 2009/4885MAPT 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.